Skip to main content

Table 3 Comparison of the non-HDL-C differences according to neurological scores

From: Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke

  Higher than normal non-HDL-C levels (208 cases) Critical high non-HDL-C levels (183 cases) Very high non-HDL-C levels (81 cases) P
NIHSS 4.0 ± 1.3 3.6 ± 1.1a 4.8 ± 1.8 0.043
NPI 3.9 ± 1.2 4.1 ± 1.2 4.9 ± 1.5ab 0.021
BI 84.1 ± 14.6 84.8 ± 14.4 82.9 ± 16.1 0.217
MMSE 24.9 ± 4.6 24.6 ± 5.1 22.6 ± 6.0ab <0.001
MoCA 20.5 ± 5.0 20.6 ± 5.9 18.3 ± 4.3ab 0.002
ADL 26.3 ± 8.2 26.5 ± 8.4 29.2 ± 10.3 0.450
HAMD 4.8 ± 1.3 4.7 ± 1.0 4.2 ± 2.7 0.634
  1. NIHSS NIH stroke score, MMSE mini-mental state examination, MoCA Montreal Cognitive Assessment, NPI, Neuropsychiatric Inventory, ADL Activity of Daily Living Scalem, HADM-21 Hamilton depression rating scale 21-item
  2. aANOVA and LSD post hoc test: P < 0.05 vs. the higher than normal non-HDL-C group
  3. bANOVA and LSD post hoc test: P < 0.05 vs. the critical high non-HDL-C group